Clinical care

Liquid chromatography-tandem mass spectrometry has a pivotal role in diagnosing intoxicated patients

What do we know so far?

A new diagnostic device may improve colposcopy and reduce the rate of cervical biopsy

Urine cathepsin C testing may offer quicker, cheaper Papillon-Lefèvre syndrome detection

Kinetic models offer a single test to predicts patients' likelihood of drug side effects.

Examining the genetic and neuropathophysiological factors in Alzheimer's disease.

Color calibration paves the way to large-scale digital pathology rollout.

Diagnostic imaging may detect fungal lung infections faster and more accurately.

What does analysis of the last five years of literature on companion diagnostics tell us about the priorities of the field, and the contributors to it?

Does point-of-care testing have a true positive effect on patient outcomes, or is it simply a perceived benefit?